Bulletin de Périodique
Lancet (The) , Vol.379, n°9810 - Jan 7, 2012 - Series: Addiction
Paru le :
07/01/2012
Langue(s) :
Anglais
Note générale :
Analyse en français des 3 articles dans le Flyer n°49, p. 22-24.
Note de contenu :
- Addiction - a global problem with no global solution [Editorial], p. 2.
Perspectives:
- Creatively confronting addiction, D. Jones, p. 20.
- Louisa Degenhardt: hooked on addiction research, T. Kirby, p. 21.
- The rise, fall, and revival of recovery in drug policy, V. Berridge, p. 22-23.
Series papers:
1- Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Degenhardt L., Hall W., p. 55-70.
2- Drug policy and the public good: evidence for effective interventions. Strang J., Babor T., Caulkins J., Fischer B., Foxcroft D., Humphreys K., p. 71-83.
3- How well do international drug conventions protect public health? Room R., Reuter P., p. 84-91.
Perspectives:
- Creatively confronting addiction, D. Jones, p. 20.
- Louisa Degenhardt: hooked on addiction research, T. Kirby, p. 21.
- The rise, fall, and revival of recovery in drug policy, V. Berridge, p. 22-23.
Series papers:
1- Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Degenhardt L., Hall W., p. 55-70.
2- Drug policy and the public good: evidence for effective interventions. Strang J., Babor T., Caulkins J., Fischer B., Foxcroft D., Humphreys K., p. 71-83.
3- How well do international drug conventions protect public health? Room R., Reuter P., p. 84-91.
Résumé :
A three-part Series assesses the global public-health toll and policy implications of drug addiction. The first paper summarises data for the prevalence and consequences of problem use of amphetamines, cannabis, cocaine, and opioids. In high-income countries, illicit drug use contributes less to the burden of disease than tobacco, but a substantial proportion of that burden is due to alcohol. Intelligent policy responses to drug problems need better prevalence data for different types of illicit drug use and the harms that their use causes globally. This need is especially urgent in high-income countries with substantial rates of illicit drug use and in low-income and middle-income countries close to illicit drug production areas. The second paper reviews existing drug policies and highlights the need for greater reliance on scientific evidence-based policy making. The final paper examines the value of international drug conventions in protecting public health.
Titre suivant :
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
L. DEGENHARDT ;
W. HALL
|
2012
Dans Lancet (The) (Vol.379, n°9810, Jan 7, 2012) Article : Périodique
Dans Lancet (The) (Vol.379, n°9810, Jan 7, 2012) Article : Périodique
FRANÇAIS :
L'article recense les résultats des études concernant la fréquence, les effets corrélés et les conséquences probables pour la santé publique de la consommation d'amphétamines, de cannabis, de cocaïne et d'opiacés.
Les auteurs font[...]
J. STRANG ;
T. F. BABOR ;
J. CAULKINS ;
B. FISCHER ;
D. R. FOXCROFT ;
K. HUMPHREYS
|
2012
Dans Lancet (The) (Vol.379, n°9810, Jan 7, 2012) Article : Périodique
Dans Lancet (The) (Vol.379, n°9810, Jan 7, 2012) Article : Périodique
Debates about which policy initiatives can prevent or reduce the damage that illicit drugs cause to the public good are rarely informed by scientific evidence. Fortunately, evidence-based interventions are increasingly being identified that are [...]
The Single Convention on Narcotic Drugs in 1961 aimed to eliminate the illicit production and non-medical use of cannabis, cocaine, and opioids, an aim later extended to many pharmaceutical drugs. Over the past 50 years international drug treati[...]
As misuse of prescription drugs increases, treating addiction to these drugs has become as crucial as preventing it. Yet best practice in this area remains elusive. David Holmes reports.